Title21 Health Solutions

Delivering innovative, integrated tech for healthcare & life sciences since 2001. Driving compliance, efficiency & quality to enhance patient safety & care.

[Title21 Health Solutions @Title21HS]

Aligned team, busy screens, and a lot of momentum behind the scenes. 👀

We’ve been working on a new way to help teams solve key industry problems, streamline critical workflows, and eliminate operational friction—and it’s almost ready to see the light of day.

Keep an eye on our feed for the official look. What’s one daily bottleneck you wish you could automate right now?

[Title21 Health Solutions @Title21HS]

Smart-AId: Batch Record Review in Minutes, Not Days

Batch record reviews that used to take days now only take minutes.

Smart-AId (of cResults), now part of the Title21 family, uses AI to turn manual, paper-based document reviews into a fully automated process. It reads, reviews, verifies, and transcribes batch records, cell therapy forms, equipment logs, and logbooks in just 1 to 2 minutes per document.

• Convert manual documentation into structured digital data that is ready for trending, reporting, and export
• Train it on any form that requires manual data entry, and it will automatically surface issues
• Integrates seamlessly with Smart-QA to provide end-to-end review automation

In advanced therapy labs where every hour matters, Smart-AId helps you speed up review cycles, improve compliance, and see documentation quality in real time.

Would you like to see it work on your own documents? With just 10 minutes of training, we can show you a live demo of Smart-AId using your actual form. Interested in learning more? Let’s talk: https://t.co/MH8yzZHckd

#AI #BatchRecords #CellAndGeneTherapy #QualityOperations #DigitalTransformation

[Title21 Health Solutions @Title21HS]

Smart-FDA: AI-Powered Regulatory Intelligence

Imagine if your whole quality team could search 15 years of FDA 483 observations using everyday language.

Now part of Title21, Smart-FDA from cResults, gives every team member access to AI-powered regulatory insights, not just compliance specialists.

You can ask questions like “What are the recent observations related to cell therapy manufacturing?” and Smart-FDA quickly highlights important trends such as CGTP compliance, supplier control, environmental monitoring, data integrity, and more.

• Search 15 years of FDA 483s, warning letters, and inspection data using conversational AI.
• Use risk questionnaires and a flexible “What If” algorithm that connects to CFR sections.
• Be ready for inspections by helping your team focus on the most important risk areas.

For advanced therapy organizations facing a rapidly changing regulatory environment, this can help you move from reacting to compliance issues to staying ahead of them. Interested? Let’s connect: https://t.co/MH8yzZHckd

#RegulatoryIntelligence #FDA #Compliance #CellAndGeneTherapy #AI

[Title21 Health Solutions @Title21HS]

How long does your batch stay “ready” without being released?

In advanced therapies, every hour of release delay means a patient waits longer. The main bottleneck often isn’t effort; it’s the lack of clear visibility across QMS, ERP, LIMS, and review systems.

Smart-QA (of cResults), now part of Title21, brings all release-critical data together in one clear view for decision-making:

• You can see pending investigations, lot genealogy, sample status, documentation errors, and open inquiries all in one place.
• Workflows are configurable, with clear task ownership and accountability.
• Real-time dashboards and KPIs help you track turnaround time and right-first-time performance.

As a result, QA teams can spot blockers right away, close gaps faster, and shorten the batch release cycle. This means therapies reach patients sooner. See it in action: https://t.co/MH8yzZHckd

#CellAndGeneTherapy #QualityAssurance #BatchRelease #AdvancedTherapies #PharmaManufacturing

[Title21 Health Solutions @Title21HS]

The future of cell and gene therapy isn't just about groundbreaking bioscience anymore - it’s about predictability, scalability, and getting these life-saving treatments to patients without delay.

Our Director of Clinical Operations, Heather Purvis, recently joined an incredible roundtable hosted by BioProcess International to discuss the "Uberization" of biotech and the massive shift toward distributed manufacturing models.

As Heather beautifully put it: " frontline teams just want this for their patients, so we need to deliver."

Moving away from centralized hubs means we can't just build closer cleanrooms; we have to eliminate compliance ambiguity. At Title21 Health Solutions, we are incredibly proud to provide the digital infrastructure and standardized workflows that empower frontline teams, enforce accountability, and bridge the gap between complex logistics and consistent patient outcomes.

📖 Catch the full discussion on rethinking CGT production and logistics here: https://t.co/8WIG2WGiro

#CellAndGeneTherapy #Biotech #DigitalTransformation #ClinicalOperations #PatientFirst #Title21

[Title21 Health Solutions @Title21HS]

Smart-QC: Digital Planning & Scheduling for QC Laboratories

In cell and gene therapy, testing windows are measured in hours, and schedules often need to be set before the sample even arrives at the lab.

This is exactly why Smart-QC was created. Now part of the Title21 family, Smart-QC from cResults offers digital planning and scheduling for QC laboratories:

• Automated scheduling for both current and future samples, with qualified and available analysts assigned before samples reach the bench
• Long- and short-term capacity planning helps identify resource gaps before they lead to missed release dates
• With over 15 real-time dashboards and more than 50 scheduling reports, you no longer need to rely on whiteboards or spreadsheets
• Equipment, reagent, and training management built right in

For advanced therapy labs, this leads to shorter cycle times, improved on-time delivery, and analysts who can focus on the science instead of the schedule. Questions? Let’s talk about them → https://t.co/MH8yzZHckd

#CellAndGeneTherapy #AdvancedTherapies #QualityControl #LabOperations #DigitalTransformation

[Title21 Health Solutions @Title21HS]

The Smart-QX Suite: Quality Operations Intelligence Now Part of Title21

Advanced therapy labs balance two priorities: meeting patient needs and following regulations. Now that cResults has joined Title21, labs can achieve both speed and compliance.

The Smart-QX suite brings a full quality operations intelligence layer to the Title21 platform:

- Smart-QC: Digital planning and scheduling designed for time-sensitive CGT testing
- Smart-QA: A clear decision view from batch record review through to release
- Smart-FDA: AI-powered regulatory insights using 15 years of FDA data
- Smart-AId: AI-powered document review that reduces work from days to minutes

Combined with Title21’s solutions suite, this forms a connected ecosystem for advanced therapy operations, covering everything from scheduling a sample to releasing a therapy to a patient.

You get more visibility, faster releases, and stronger compliance. That’s the value Smart-QX brings to Title21. Want to learn more? Let’s chat → https://t.co/MH8yzZHckd

#CellAndGeneTherapy #AdvancedTherapies #QualityOperations #DigitalTransformation #LifeSciences

[Title21 Health Solutions @Title21HS]

We are pleased to announce that Title21 has acquired cResults.

Life sciences quality teams now have access to purpose-built resource planning and scheduling tools, enhancing the Title21 platform.

Read the announcement: https://t.co/KgyhyLgbph

#Title21 #cResults #LifeSciences

[Title21 Health Solutions @Title21HS]

At this year’s ASGCT meeting, the big takeaway wasn't just about groundbreaking discoveries; it was about solving the real-world infrastructure challenges that stand between the bench and the bedside.

Our Director of Clinical Operations, Heather Purvis, broke down the key takeaways from ASGCT 2026:

• Bridging the R&D Digital Gap: Why early-stage research is still paper-heavy, and the bridge tools needed to help labs scale.
• Cracking the Code on Non-Responders: Shifting the focus toward why therapies sometimes stop working, especially in complex solid tumors.
• Overcoming Translational Barriers: Tackling the infrastructure, standard frameworks, and cost structures required for commercial success.

Swipe through the graphics below for a deeper dive into Heather’s full insights. 👇

#ASGCT2026 #CellAndGeneTherapy #DigitalTransformation #Biotherapy

[Title21 Health Solutions @Title21HS]

Happy Clinical Trials Day! Today, we are celebrating #ResearchRising - a theme that honors the incredible momentum of clinical research and the dedication of the professionals, scientists, and patients driving medical breakthroughs forward.

Clinical trials are the cornerstone of modern medicine, but bringing a new therapy to life is an intricate journey. It requires precise data integrity, flawless regulatory compliance, and seamless collaboration across global teams to ensure patient safety every step of the way.

At Title21, we are incredibly proud to support the clinical research ecosystem by providing the digital quality foundations that keep data secure and workflows moving efficiently. When the operational infrastructure is solid, life-changing research can truly rise.

Thank you to all the trailblazers rewriting the future of healthcare! 🔬✨

#ClinicalTrialsDay #ResearchRising #ClinicalResearch #LifeSciences #MedicalInnovation #DataIntegrity #Title21

[Title21 Health Solutions @Title21HS]

We had a fantastic time at ASGCT 2026 connecting with the pioneers who are pushing the boundaries of genetic medicine. From inspiring sessions to great conversations on the floor, we're leaving more motivated than ever to support the future of digital orchestration in CGT.

A huge thank you to everyone who took the time to connect with us, and to our Director of Clinical Operations, Heather Purvis, for representing the Title21 team on the ground!

See below for just a few of the highlights from the week. 📸👇

#ASGCT2026 #GeneTherapy #DigitalTransformation #Title21 #Biotech #Boston

[Title21 Health Solutions @Title21HS]

Boston has been incredible!

Spending the week at ASGCT 2026 has been a powerful reminder of why we do this work. Connecting with the pioneers advancing genetic medicines brings the true urgency of this industry into sharp focus - reminding us that behind every workflow we digitize and streamline, there are real patients and families waiting.

Thank you to everyone who shared their mission with us this week. We’re leaving Boston more motivated than ever to help accelerate the delivery of these life-saving therapies. 🧬

#ASGCT2026 #GeneTherapy #DigitalTransformation #Title21 #Biotech

[Title21 Health Solutions @Title21HS]

ISCT 2026 in Dublin was full of innovation and insight!

Between the sessions and networking, a few major themes stood out regarding the future of supply chain resilience and the practical role of AI in GMP. We’ve distilled our top 3 takeaways from ISCT 2026 that are shaping how we think about digital orchestration this year.

Curious about where the industry is heading?

Check out our key findings below! 👇

#ISCT2026 #CellAndGeneTherapy #DigitalTransformation #Title21 #Biotherapy #IndustryInsights

[Title21 Health Solutions @Title21HS]

ASGCT 2026 is officially underway in Boston!

Heather Purvis is on the ground and would love to hear about the work your team is doing.

📅 Book a time to chat with Heather here: https://t.co/5cQBmJL0Yt

Looking forward to a great week in Boston! 🧬

#ASGCT2026 #GeneTherapy #DigitalTransformation #Title21 #Biotech #Boston

[Title21 Health Solutions @Title21HS]

Title21 Health Solutions is officially headed to Boston for ASGCT 2026!

Our Director of Clinical Operations, Heather Purvis, will be on-site and ready to discuss the digital roadmap to faster treatment delivery.

Want to connect in Boston?
📅 Book a spot to meet with Heather here: https://t.co/5cQBmJL0Yt

See you at the meeting!

#ASGCT2026 #GeneTherapy #CellTherapy #DigitalHealth #Title21 #BostonTech

[Title21 Health Solutions @Title21HS]

Dublin has been incredible so far! We’ve spent the last few days having some truly inspiring conversations about the future of cell and gene therapy and the impact of digital transformation.

But we���re not done yet. Toon Lambrechts is still on-site and would love to hear about the challenges you're solving and how Title21 can support your mission.

📅 You can grab a spot on his schedule here: https://t.co/dq9meaNTwE

Looking forward to a strong finish to the week! ☘️

#ISCT2026 #CellAndGeneTherapy #DigitalHealth #Title21 #Dublin #Biotherapy

[Title21 Health Solutions @Title21HS]

Happy National Nurses Day! 🩺✨

To the nurses who show up every day with unmatched heart and expertise- thank you. You are the true backbone of healthcare, and your dedication to patient safety and care is what keeps the industry moving forward.

Since May also highlights oncologic nursing, we want to send an extra shout-out to those providing specialized support and strength to patients through their toughest journeys.

We’re incredibly grateful for everything you do.

#NationalNursesDay #NursesWeek #OncologyNursing #HealthcareHeroes #PatientCare #ThankYouNurses

[Title21 Health Solutions @Title21HS]

Tomorrow is the day; ISCT 2026 officially kicks off in Dublin!

Toon Lambrechts will be on the ground and ready to dive into all things digital transformation and cell therapy orchestration. If you’re looking to move away from paper-based hurdles and streamline your workflows, we’d love to connect.

📅 Book a spot to meet with Toon below.

See you tomorrow! ☘️

#ISCT2026 #CellAndGeneTherapy #DigitalHealth #Title21 #Dublin #Biotherapy

[Title21 Health Solutions @Title21HS]

We’re thrilled to announce that Title21 Health Solutions is heading to Dublin for ISCT 2026!

Toon Lambrechts, our Global Manager of Biotherapy Manufacturing, will be there to talk about our newest technology that makes your workflows smoother while keeping everything compliant from collection to care.

📅 Book a time to meet with him here: https://t.co/dq9meaNTwE

Let’s chat about how Title21 can help you deliver life-saving therapies to patients faster. See you in Dublin! ☘️

#ISCT2026 #CellAndGeneTherapy #DigitalTransformation #Biotherapy #Dublin

[Title21 Health Solutions @Title21HS]

Will you be at ASGCT 2026 in Boston?

Our director of Clinical Operations, Heather Purvis, will be on the ground and ready to dive into your team's specific digital roadmap and goals.

📅 Book a time to connect with Heather here: https://t.co/5cQBmJL0Yt

See you in Boston! 🧬

#ASGCT2026 #GeneTherapy #DigitalTransformation #Title21 #Biotech #Boston

[Title21 Health Solutions @Title21HS]

Heading to Dublin for ISCT 2026? Don't miss the chance to talk digital orchestration with the Title21 team!☘️

Title21's Global Manager of Biotherapy Manufacturing, Toon Lambrechts, will be on-site to share the insights on how we’re helping labs move beyond paper-based limitations.

📅 Book a spot to meet with Toon here: https://t.co/dq9meaNTwE

#ISCT2026 #CellAndGeneTherapy #DigitalTransformation #Title21 #Biotherapy #Dublin